-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Axogen, Raises Price Target to $37

Benzinga·12/05/2025 19:11:30
Listen to the news
Canaccord Genuity analyst Caitlin Cronin maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $27 to $37.